Rheumatoid arthritis
Diabetes or immediate family history of diabetes
Coronary artery disease
Congestive heart failure
Pulmonary disorders, including COPD and asthma
Malabsorptive GI disease, such as celiac disease, or gastric bypass
Significant hepatic disease
Renal insufficiency (eGFR < 60 mL/kg/min)
Anemia (hematocrit < 34%) as measured at screening visit
Pregnant females
Consumption of daily medications that alter glucose metabolism of GI function (glucocorticoids, psychotropics, narcotics, metoclopramide)
Consumption or injection of insulin
Apparent sensitivity to any of the study peptides as determined by the skin test
Diagnosis or h/o PTSD, depression, substance use, mental health problems, sleep disorders, HPA disruption and/or TBI

NCT02844907_exc_T1
Condition
Rheumatoid arthritis
NCT02844907_exc_T2
Condition
Diabetes
NCT02844907_exc_T3
Observation
immediate family history
NCT02844907_exc_T4
Condition
diabetes
NCT02844907_exc_T5
Condition
Coronary artery disease
NCT02844907_exc_T6
Condition
Congestive heart failure
NCT02844907_exc_T7
Condition
Pulmonary disorders
NCT02844907_exc_T8
Condition
COPD
NCT02844907_exc_T9
Condition
asthma
NCT02844907_exc_T10
Scope
COPD and asthma
NCT02844907_exc_T11
Condition
Malabsorptive GI disease
NCT02844907_exc_T12
Condition
celiac disease
NCT02844907_exc_T13
Procedure
gastric bypass
NCT02844907_exc_T14
Scope
celiac disease, or gastric bypass
NCT02844907_exc_T15
Qualifier
Significant
NCT02844907_exc_T16
Condition
hepatic disease
NCT02844907_exc_T17
Condition
Renal insufficiency
NCT02844907_exc_T18
Measurement
eGFR
NCT02844907_exc_T19
Value
< 60 mL/kg/min
NCT02844907_exc_T20
Scope
eGFR < 60 mL/kg/min
NCT02844907_exc_T21
Condition
Anemia
NCT02844907_exc_T22
Measurement
hematocrit
NCT02844907_exc_T23
Value
< 34%
NCT02844907_exc_T24
Visit
screening visit
NCT02844907_exc_T25
Scope
hematocrit < 34%
NCT02844907_exc_T26
Condition
Pregnant
NCT02844907_exc_T27
Person
females
NCT02844907_exc_T28
Multiplier
daily
NCT02844907_exc_T29
Drug
medications
NCT02844907_exc_T30
Qualifier
that alter glucose metabolism of GI function
NCT02844907_exc_T31
Drug
glucocorticoids
NCT02844907_exc_T32
Drug
psychotropics
NCT02844907_exc_T33
Drug
metoclopramide
NCT02844907_exc_T34
Drug
narcotics
NCT02844907_exc_T35
Scope
glucocorticoids, psychotropics, narcotics, metoclopramide
NCT02844907_exc_T36
Drug
insulin
NCT02844907_exc_T37
Procedure
injection
NCT02844907_exc_T38
Drug
insulin
NCT02844907_exc_T39
Condition
sensitivity
NCT02844907_exc_T40
Drug
study peptides
NCT02844907_exc_T41
Procedure
skin test
NCT02844907_exc_T42
Condition
PTSD
NCT02844907_exc_T43
Condition
depression
NCT02844907_exc_T44
Condition
substance use
NCT02844907_exc_T45
Condition
mental health problems
NCT02844907_exc_T46
Condition
sleep disorders
NCT02844907_exc_T47
Condition
HPA disruption
NCT02844907_exc_T48
Condition
TBI